Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0001013762-25-000233·Pasithea Therapeutics Corp.
Schedule 13D ownership disclosure
PASITHEA THERAPEUTICS CORP
Common Stock, par value $0.0001 per share · CUSIP: 70261F202
Event date: 2025-03-01
- Filing-level shares
- 83,858.00
- Percent of class
- 3.1%
- Lawrence SteinmanReported CIK 0001132679
Shares: 83,858.00 · Class: 3.1%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001013762-25-000233
- Form type
- SCHEDULE 13D/A
- Filer
- Pasithea Therapeutics Corp.
- CIK
- CIK 1841330
- Filed
- Mar 06, 2025
- Reporting period
- Mar 01, 2025
- Description
- Schedule 13D beneficial ownership